ACTRN12623001119684尚未招募3 期
Effect and time course of topical ketotifen 0.025% and prednisolone sodium phosphate 0.5% on ocular dendritic cell density, morphology, and topographical distribution in participants with allergic conjunctivitis
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Be at least 18 years of age or older.
- •2. Positive result in the skin prick test.
- •3. All participants must have current active allergic conjunctivitis symptoms (including itchy eyes or watery eyes or burning feeling or feeling like there is dirt or grit in your eyes) or signs (including redness or conjunctival chemosis or conjunctival papillae or conjunctival follicles), with or without a prior diagnosis of ocular allergy or hay fever.
- •4. Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
排除标准
- •1. Severe allergic conjunctivitis (reflective from the total symptoms scores of the Mini-RQLQ and OSDI questionnaires) including vernal keratoconjunctivitis and atopic keratoconjunctivitis.
- •2. Negative result in the skin prick test.
- •3. Severe asthma.
- •4. Severe eczema.
- •5. Past anaphylactic episode.
- •6. Previous allergic reaction to any component of topical eyedrops used in this study including benzalkonium chloride preservative.
- •7. Pregnant or breastfeeding/childbirth within three months from the date of recruitment.
- •8. Regular contact lens wear (wearing contact lenses for at least two or more full days in a week).
- •9. All other ocular surface diseases except allergic conjunctivitis.
- •10. Ocular diseases that involve the cornea.
- •11. Active intraocular inflammation.
- •12. History of corneal refractive surgery.
- •13. Systematic conditions affecting the ocular surface include diabetes, thyroid disorder, rheumatoid arthritis and Sjogren's syndrome.
研究者
相似试验
进行中（未招募）
不适用
Efficacy and tolerability of topical Ketoprofen TDS patch KEOFIX in the treatment of traumatic painful soft-tissue injuriesMedDRA version: 6.1Level: PTClassification code 10023229ANKLE SPRAINEUCTR2004-000843-61-ITZAMBON GROUP200
已完成
3 期
Effect of topical ketorolac and tetracaine on the need for sedative and analgesic drugs in phacoemulsificatioCataract.Age-related cataractIRCT20170716035104N4Esfahan University of Medical Sciences86
尚未招募
2 期
The effect of topical ketorolac on knee osteoarthritisOsteoarthritis of kneeKnee osteoarthritis.IRCT20190810044500N22Yazd University of Medical Sciences40
已完成
3 期
Ketoprofen Topical Patch, 20% in the Treatment of Pain Associated With Osteoarthritis Flare of the KneeOsteoarthritisNCT00365586APR Applied Pharma Research s.a.300
尚未招募
不适用
Effect, safety and action of Ketotifen associated with Famotidine in the treatment of facial stains.Skin disordersC16.131.831RBR-7g4gp4Faculdade de Medicina de Botucatu (FMB - Unesp)